Search Result "Receptor activator of nuclear factor-κB ligand (RANKL)"
Regulation and Function of Rankl in Arterial Calcification
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5853-5861
Author(s): Belinda A. Di Bartolo, Mary M. Kavurma
Current Status and Future Prospects of Smallâmolecule Proteinâprotein Interaction (PPI) Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
Journal: Current Topics in Medicinal Chemistry
Volume: 18 Issue: 8 Year: 2018 Page: 661-673
Author(s): Georgia Melagraki,Georgios Leonis,Evangelos Ntougkos,Vagelis Rinotas,Christos Papaneophytou,Thomas Mavromoustakos,George Kontopidis,Eleni Douni,George Kollias,Antreas Afantitis
RANKL/RANK/OPG: Key Therapeutic Target in Bone Oncology
Journal: Current Drug Discovery Technologies
Volume: 5 Issue: 3 Year: 2008 Page: 263-268
Author(s): Kosei Ando, Kanji Mori, Francoise Redini, Dominique Heymann
Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer
Journal: Current Drug Targets
Volume: 18 Issue: 2 Year: 2017 Page: 232-253
Author(s): Javadi Monisha,Nand Kishor Roy,Devivasha Bordoloi,Amit Kumar,Ramesh Golla,Jibon Kotoky,Ganesan Padmavathi,Ajaikumar B. Kunnumakkara
Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 1 Year: 2010 Page: 1272-1283
Author(s): C.H. Buckle, H.L. Neville-Webbe, P.I. Croucher, M.A. Lawson
Recent Advance in Epigenetics - Application to The Regulation of Osteoclast Differentiation
Journal: Current Rheumatology Reviews
Volume: 8 Issue: 2 Year: 2012 Page: 103-108
Author(s): Tetsuro Yasui,Jun Hirose,Hiroyuki Aburatani,Sakae Tanaka
Potential Role of Rebamipide in Osteoclast Differentiation and Mandibular Condylar Cartilage Homeostasis
Journal: Current Rheumatology Reviews
Volume: 14 Issue: 1 Year: 2018 Page: 62-69
Author(s): Takashi Izawa,Islamy Rahma Hutami,Eiji Tanaka
Lanthanum Hydroxide and Chronic Kidney Disease Mineral and BoneDisorder: A Rat Model
Journal: Current Vascular Pharmacology
Volume: 22 Issue: 2 Year: 2024 Page: 122-136
Author(s):
Understanding and Targeting Osteoclastic Activity in Prostate Cancer Bone Metastases
Journal: Current Molecular Medicine
Volume: 13 Issue: 4 Year: 2013 Page: 626-639
Author(s): J.L. Sottnik, E.T. Keller
Molecular Signaling Pathways and Essential Metabolic Elements in Bone Remodeling: An Implication of Therapeutic Targets for Bone Diseases
Journal: Current Drug Targets
Volume: 22 Issue: 1 Year: 2021 Page: 77-104
Author(s): Aditi Sharma,Lalit Sharma,Rohit Goyal